Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune features in complete Freund adjuvant-treated CBA/J mouse model.

D Strassburger1, Y Irlin, H Carp

  • 1Department of Embryology, Tel-Aviv University Medical School, Israel.

American Journal of Reproductive Immunology (New York, N.Y. : 1989)
|October 1, 1992
PubMed
Summary

Complete Freund

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced immunogenicity of multivalent MUC1 glycopeptide antitumour vaccines based on hyperbranched polymers.

Organic & biomolecular chemistry·2015
Same author

Thymic hormones: inducers and.

Immunology today·2014
Same author

Effect of seminal plasma application to the vaginal vault in in vitro fertilization or intracytoplasmic sperm injection treatment cycles-a double-blind, placebo-controlled, randomized study.

Journal of assisted reproduction and genetics·2013
Same author

Surrogate in vitro fertilization outcome in typical and atypical forms of Mayer-Rokitansky-Kuster-Hauser syndrome.

Human reproduction (Oxford, England)·2011
Same author

Presence of IL-18 in testicular tissue of fertile and infertile men.

Andrologia·2011
Same author

EGF-like growth factors as LH mediators in the human corpus luteum.

Human reproduction (Oxford, England)·2008

Area of Science:

  • Immunology
  • Reproductive immunology

Background:

  • Fetal loss is a concern in pregnancy.
  • Complete Freund adjuvant (CFA) has shown potential in preventing fetal loss.

Purpose of the Study:

  • To investigate the immunological mechanisms behind CFA's protective effect against fetal loss.
  • To analyze changes in lymphocyte populations after CFA treatment.

Main Methods:

  • Mice (CBA/J x DBA/2J) were treated with CFA.
  • Splenocyte responses to paternal alloantigens were measured.
  • Lymphocyte populations (asialo GM-1, HNK-1, L3T4, Lyt-2, Mac-1) were analyzed in spleen, lymph nodes, and placenta.

Main Results:

  • CFA treatment diminished maternal splenocyte responses to paternal alloantigens.

Related Experiment Videos

  • Lymphocytes from spleen, lymph nodes, and placenta suppressed maternal responses.
  • Elevated asialo GM-1 and HNK-1 cells were observed, with no change in L3T4 or Lyt-2 cells.
  • Mac-1 positive cells significantly increased in the placenta of CFA-treated animals.

    • Conclusions:

    • CFA-induced immunostimulation alters maternal immune cell populations.
    • Specific immune cell changes, particularly Mac-1 positive cells in the placenta, may contribute to fetal protection.
    • Further research is needed to confirm the role of these changes in preventing fetal resorption.